2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Medulloblastoma
1
Ependymoma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
1495
Cisplatin
1431
Paclitaxel
1339
Radiotherapy
1308
Carboplatin
1264
Gemcitabine
1225
Docetaxel
1134
Bevacizumab
1068
Fluorouracil
906
Doxorubicin
799
Dexamethasone
753
Rituximab
744
Capecitabine
735
Oxaliplatin
709
pembrolizumab
693
Etoposide
674
Irinotecan
639
Filgrastim
624
Nivolumab
585
Cytarabine
585
Leucovorin
582
Vincristine
512
Cetuximab
478
Prednisone
477
Bortezomib
472
Trastuzumab
469
Erlotinib Hydrochloride
467
Surveys and Questionnaires
460
Methotrexate
443
Lenalidomide
434
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
trofosfamide
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled
NCT00749723
2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3
Completed
174 enrolled